Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Edaravone, the first known free radical scavenger, has demonstrated cellular protective properties in animals and humans. Owing to its antioxidant activity, edaravone modulates oxidative damage in various diseases, especially neurodegenerative diseases. In 2015, edaravone was approved in Japan to tr...

Description complète

Détails bibliographiques
Auteurs principaux: Sun Joo Cha, Kiyoung Kim
Format: Article
Langue:English
Publié: MDPI AG 2022-01-01
Collection:Antioxidants
Sujets:
Accès en ligne:https://www.mdpi.com/2076-3921/11/2/195

Documents similaires